Cross-link between ferroptosis and nasopharyngeal carcinoma: New approach to radiotherapy sensitization

Hai-Long Li1, Nian-Hua Deng2, Jia-Xin Xiao1

  • 1Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Cancer Research Institute of Medical College, University of South China, Hengyang, Hunan 421001, P.R. China.

Oncology Letters
|September 30, 2021
PubMed

Insights

Ferroptosis, a cell death form, shows potential in treating various cancers. This review explores its role and radiosensitization mechanisms in nasopharyngeal carcinoma (NPC) for new therapeutic strategies.

Area of Science:

  • Oncology
  • Cell Death Research
  • Cancer Therapeutics

Background:

  • Ferroptosis is a regulated cell death pathway implicated in homeostasis and cancer.
  • Small molecules inducing ferroptosis show promise for treating breast, pancreatic, prostate, and head and neck cancers.
  • The role of ferroptosis in nasopharyngeal carcinoma (NPC) remains largely undetermined.

Purpose of the Study:

  • To review the current understanding of ferroptosis in nasopharyngeal carcinoma (NPC).
  • To explore the potential of ferroptosis regulators as therapeutic targets in NPC.
  • To discuss the mechanism of ferroptosis in NPC radiosensitization.

Main Methods:

  • Literature review of existing studies on ferroptosis and NPC.
  • Analysis of gene expression and metabolic pathways related to ferroptosis.
  • Discussion of potential therapeutic strategies involving ferroptosis induction and radiotherapy.

Main Results:

  • Ferroptosis is linked to cancer development and treatment across multiple cancer types.
  • Specific genes and metabolic pathways regulate ferroptosis, offering potential therapeutic targets.
  • Ferroptosis induction may enhance radiosensitivity in NPC treatment.

Conclusions:

  • Ferroptosis represents a promising area for novel therapeutic strategies in NPC.
  • Understanding ferroptosis mechanisms can lead to improved radiotherapy approaches for NPC.
  • Further research into ferroptosis regulators is crucial for developing targeted NPC therapies.